Latest
New stroke-prevention drug approaches U.S. rollout after first-in-class approval
Sunharbo reduced ischemic stroke risk in a large trial, but its approval covers a defined group of patients and treatment still carries bleeding risks.
The latest Health & Biotech stories, each checked against primary sources and approved by an editor.
Latest
Sunharbo reduced ischemic stroke risk in a large trial, but its approval covers a defined group of patients and treatment still carries bleeding risks.